Mirae Asset Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank -
Rating
Growth Option 13-03-2026
NAV ₹38.56(R) -2.03% ₹43.4(D) -2.03%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 11.62% 25.05% 15.83% 20.53% -%
Direct 13.23% 26.89% 17.57% 22.39% -%
Nifty Pharma TRI 12.8% 26.24% 14.52% 14.92% 7.65%
SIP (XIRR) Regular 4.05% 14.23% 14.88% 18.34% -%
Direct 5.57% 15.98% 16.59% 20.2% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
1.13 0.61 1.0 0.6% -0.39
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
16.43% -19.03% -15.31% 0.94 11.47%
Fund AUM As on: 30/12/2025 2807 Cr
Top Pharma Fund
Fund Name Rank Rating
Mirae Asset Healthcare Fund -

NAV Date: 13-03-2026

Scheme Name NAV Rupee Change Percent Change
Mirae Asset Healthcare Fund Regular IDCW 22.7
-0.4700
-2.0300%
Mirae Asset Healthcare Fund Direct IDCW 26.14
-0.5400
-2.0300%
Mirae Asset Healthcare Fund -Regular Growth 38.56
-0.8000
-2.0300%
Mirae Asset Healthcare Fund Direct Growth 43.4
-0.9000
-2.0300%

Review Date: 13-03-2026

Beginning of Analysis

The Mirae Asset Healthcare Fund has shown a very good past performence in Pharma Fund. The Mirae Asset Healthcare Fund has a Jensen Alpha of 0.6% which is lower than the category average of 1.56%, showing poor performance. The Mirae Asset Healthcare Fund has a Sharpe Ratio of 1.13 which is lower than the category average of 1.19, showing poor performance.
The past performance of the {fund_name_eng} may or may not be sustained in the future. The review is not investment advice nor is it a recommendation to buy or sell funds.
Pharma Mutual Funds

Mirae Asset Healthcare Fund Return Analysis

The Mirae Asset Healthcare Fund has delivered a mixed performance across various time horizons, showcasing both strengths and challenges when compared to its Pharma Fund peers and the Nifty Pharma TRI benchmark. This analysis examines the fund’s returns over periods ranging from one month to ten years, alongside its Systematic Investment Plan (SIP) performance, highlighting its rankings within the Pharma Fund category and its ability to outperform or underperform the benchmark and category averages.

  • The fund has given a return of 2.53%, 1.19 and -0.62 in last one, three and six months respectively. In the same period the category average return was -0.15%, -2.19% and -3.48% respectively.
  • Mirae Asset Healthcare Fund has given a return of 13.23% in last one year. In the same period the Nifty Pharma TRI return was 12.8%. The fund has given 0.43% more return than the benchmark return.
  • The fund has given a return of 26.89% in last three years and rank 2nd out of six funds in the category. In the same period the Nifty Pharma TRI return was 26.24%. The fund has given 0.65% more return than the benchmark return.
  • Mirae Asset Healthcare Fund has given a return of 17.57% in last five years and category average returns is 16.73% in same period. The fund ranked 2.0nd out of six funds in the category. In the same period the Nifty Pharma TRI return was 14.52%. The fund has given 3.05% more return than the benchmark return.
  • The fund has given a SIP return of 5.57% in last one year whereas category average SIP return is -0.42%. The fund one year return rank in the category is 1st in 12 funds
  • The fund has SIP return of 15.98% in last three years and ranks 1st in 5 funds. The fund has given the highest SIP return in the category in last three years.
  • The fund has SIP return of 16.59% in last five years whereas category average SIP return is 16.06%.

Mirae Asset Healthcare Fund Risk Analysis

  • The fund has a standard deviation of 16.43 and semi deviation of 11.47. The category average standard deviation is 15.51 and semi deviation is 10.99.
  • The fund has a Value at Risk (VaR) of -19.03 and a maximum drawdown of -15.31. The category average VaR is -18.18 and the maximum drawdown is -14.76. The fund has a beta of 0.94 which shows that fund is less volatile than the benchmark.

Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.


  • Very Good Performance in Pharma Fund Category
  • Good Performance in Pharma Fund Category
  • Poor Performance in Pharma Fund Category
  • Very Poor Performance in Pharma Fund Category

    • Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

    Data Source: www.amfiindia.com

    SEBI Categorization


    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % 2.41 2.94
    -0.25
    		-2.34 | 2.41 1 | 14 Very Good
    3M Return % 0.84 0.72
    -2.50
    		-5.86 | 0.84 1 | 14 Very Good
    6M Return % -1.33 3.11
    -4.13
    		-7.22 | -0.41 2 | 14 Very Good
    1Y Return % 11.62 12.80
    8.88
    		4.82 | 12.89 3 | 13 Very Good
    3Y Return % 25.05 26.24
    24.86
    		23.39 | 27.56 3 | 6 Good
    5Y Return % 15.83 14.52
    15.34
    		14.14 | 16.86 2 | 6 Very Good
    7Y Return % 20.53 14.92
    19.49
    		18.52 | 20.87 2 | 5 Very Good
    1Y SIP Return % 4.05
    -1.49
    		-6.58 | 4.05 1 | 13 Very Good
    3Y SIP Return % 14.23
    12.69
    		10.62 | 14.23 1 | 6 Very Good
    5Y SIP Return % 14.88
    14.56
    		13.45 | 16.51 2 | 6 Very Good
    7Y SIP Return % 18.34
    17.79
    		16.49 | 19.41 2 | 5 Very Good
    Standard Deviation 16.43
    15.51
    		14.34 | 16.43 8 | 8 Poor
    Semi Deviation 11.47
    10.99
    		9.99 | 11.68 6 | 8 Average
    Max Drawdown % -15.31
    -14.76
    		-16.36 | -12.33 4 | 8 Good
    VaR 1 Y % -19.03
    -18.18
    		-21.68 | -15.67 6 | 8 Average
    Average Drawdown % -6.40
    -5.42
    		-6.79 | -3.66 7 | 8 Poor
    Sharpe Ratio 1.13
    1.19
    		1.08 | 1.37 5 | 8 Average
    Sterling Ratio 1.00
    1.02
    		0.92 | 1.18 5 | 8 Average
    Sortino Ratio 0.61
    0.63
    		0.56 | 0.72 6 | 8 Average
    Jensen Alpha % 0.60
    1.56
    		-0.45 | 4.64 5 | 8 Average
    Treynor Ratio -0.39
    -0.42
    		-0.47 | -0.39 1 | 8 Very Good
    Modigliani Square Measure % 25.50
    26.49
    		24.56 | 29.65 5 | 8 Average
    Alpha % -2.00
    -1.30
    		-2.78 | 1.82 6 | 8 Average
    Return data last Updated On : March 13, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Feb. 27, 2026
    KPIs: Key Performance Indicators

    Rotate the phone! Best viewed in landscape mode on mobile.
    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % 2.53 2.94 -0.15 -2.22 | 2.53 1 | 14 Very Good
    3M Return % 1.19 0.72 -2.19 -5.70 | 1.19 1 | 14 Very Good
    6M Return % -0.62 3.11 -3.48 -6.75 | 0.40 2 | 14 Very Good
    1Y Return % 13.23 12.80 10.38 6.15 | 14.22 3 | 13 Very Good
    3Y Return % 26.89 26.24 26.32 24.88 | 28.62 2 | 6 Very Good
    5Y Return % 17.57 14.52 16.73 15.75 | 17.87 2 | 6 Very Good
    7Y Return % 22.39 14.92 20.91 19.72 | 22.39 1 | 5 Very Good
    1Y SIP Return % 5.57 -0.42 -4.99 | 5.57 1 | 12 Very Good
    3Y SIP Return % 15.98 14.12 12.37 | 15.98 1 | 5 Very Good
    5Y SIP Return % 16.59 16.06 15.03 | 17.53 2 | 5 Very Good
    7Y SIP Return % 20.20 19.21 18.31 | 20.53 2 | 5 Very Good
    Standard Deviation 16.43 15.51 14.34 | 16.43 8 | 8 Poor
    Semi Deviation 11.47 10.99 9.99 | 11.68 6 | 8 Average
    Max Drawdown % -15.31 -14.76 -16.36 | -12.33 4 | 8 Good
    VaR 1 Y % -19.03 -18.18 -21.68 | -15.67 6 | 8 Average
    Average Drawdown % -6.40 -5.42 -6.79 | -3.66 7 | 8 Poor
    Sharpe Ratio 1.13 1.19 1.08 | 1.37 5 | 8 Average
    Sterling Ratio 1.00 1.02 0.92 | 1.18 5 | 8 Average
    Sortino Ratio 0.61 0.63 0.56 | 0.72 6 | 8 Average
    Jensen Alpha % 0.60 1.56 -0.45 | 4.64 5 | 8 Average
    Treynor Ratio -0.39 -0.42 -0.47 | -0.39 1 | 8 Very Good
    Modigliani Square Measure % 25.50 26.49 24.56 | 29.65 5 | 8 Average
    Alpha % -2.00 -1.30 -2.78 | 1.82 6 | 8 Average
    Return data last Updated On : March 13, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Feb. 27, 2026
    KPIs: Key Performance Indicators

    Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


    Date Mirae Asset Healthcare Fund NAV Regular Growth Mirae Asset Healthcare Fund NAV Direct Growth
    13-03-2026 38.564 43.4
    12-03-2026 39.364 44.299
    11-03-2026 39.556 44.513
    10-03-2026 39.436 44.376
    09-03-2026 38.937 43.814
    06-03-2026 39.078 43.966
    05-03-2026 39.121 44.014
    04-03-2026 38.512 43.326
    02-03-2026 39.06 43.939
    27-02-2026 39.237 44.133
    26-02-2026 39.551 44.485
    25-02-2026 39.091 43.965
    24-02-2026 38.584 43.393
    23-02-2026 38.461 43.253
    20-02-2026 38.148 42.896
    19-02-2026 38.156 42.904
    18-02-2026 38.309 43.074
    17-02-2026 38.214 42.965
    16-02-2026 37.996 42.719
    13-02-2026 37.655 42.33

    Fund Launch Date: 11/Jun/2018
    Fund Category: Pharma Fund
    Investment Objective: The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.
    Fund Description: Healthcare Fund - An open ended e q u i t y scheme investing i n healthcare and allied sectors
    Fund Benchmark: S&P BSE Healthcare Index (Total Return Index)
    Source: Fund FactSheet

    Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.